Regenerating CNS myelin — from mechanisms to experimental medicines
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Franklin, RJM
Abstract
Abstract | Although the core concept of remyelination — based on the activation, migration, proliferation and differentiation of CNS progenitors — has not changed over the past 20 years, our understanding of the detailed mechanisms that underlie this process has developed considerably. We can now decorate the central events of remyelination with a host of pathways, molecules, mediators and cells, revealing a complex and precisely orchestrated process. These advances have led to recent drug-based and cell-based clinical trials for myelin diseases, and have opened up hitherto unrecognized opportunities for drug-based approaches to therapeutically enhance remyelination.
Description
Keywords
Animals, Cell Differentiation, Central Nervous System, Demyelinating Diseases, Humans, Myelin Sheath, Nerve Regeneration, Oligodendroglia
Journal Title
Nature Reviews Neuroscience
Conference Name
Journal ISSN
1471-003X
1471-0048
1471-0048
Volume Title
18
Publisher
Springer Nature
Publisher DOI
Sponsorship
Medical Research Council (MC_PC_12009)
Medical Research Council (G0802545)
Medical Research Council (G0802545)
None acknowledged.